Arbutus Biopharma
ABUS
#6550
Rank
A$1.05 B
Marketcap
A$5.47
Share price
4.63%
Change (1 day)
2.78%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): A-$0.40

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is A-$0.37. In 2024 the company made an earnings per share (EPS) of A-$0.54 an increase over its 2023 EPS that were of A-$0.63.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.40-26.42%
2024A-$0.54-13.64%
2023A-$0.63-4.35%
2022A-$0.66-44.58%
2021A-$1.18-17%
2020A-$1.42-65.4%
2019A-$4.12138.84%
2018A-$1.72-22.44%
2017A-$2.22-78.45%
2016A-$10.31424.64%
2015A-$1.97-20.19%
2014A-$2.4687.96%
2013A-$1.31-142.59%
2012A$3.08-342.7%
2011A-$1.27-25.82%
2010A-$1.7147.8%
2009A-$1.16-43.55%
2008A-$2.05158.91%
2007A-$0.79-111.88%
2006A$6.66-552.53%
2005A-$1.47-71.77%
2004A-$5.21-14.48%
2003A-$6.09-8.95%
2002A-$6.6970.07%
2001A-$3.9448.01%
2000A-$2.66-38.54%
1999A-$4.33-24.6%
1998A-$5.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
A-$0.08545-76.92% Bahamas
NRC Health
NRC
A$1.00-369.23%๐Ÿ‡บ๐Ÿ‡ธ USA